Conclusion Sunitinib inhibited bladder cell line T24 proliferation in dose-dependent and time dependent manner.

结论苹果酸舒尼替尼可呈浓度和时间依赖地抑制膀胱癌t 24细胞系增殖。

youdao

Conclusions: Sunitinib inhibited bladder cell line T24 proliferation in dose-dependent and time dependent manner.

结论：苹果酸舒尼替尼可呈浓度和时间依赖地抑制膀胱癌t 24细胞系增殖。

youdao

Purpose:To study the reversal effects on multidrug resistance in multidrug-resistent bladder cell lines BIU-87/ADM.

目的：研究卡维地洛对人膀胱癌耐药细胞株BIU-87/ADM的多药耐药性逆转作用。

youdao

Vandetanib, the drug approved today, failed in non-small cell lung cancer and in bladder cancer before it proved effective in medullary thyroid cancer.

FORBES: AstraZeneca's Victory Highlights Difficulty Of Cancer Drug Development